Live courses

Title Credit Cost Datessort descending
Monthly Oncology Tumor Boards: Identification and Management of Immuno-Oncology Targeted Therapy-Related Adverse Events in Renal Cell Carcinoma
    • 1.00 CCM clock hours
    • 1.00 ANCC contact hours
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ACPE contact hours
    • 1.00 AAPA Category 1 CME credit
    • 1.00 Participation
 $0.00 10/17/2023 - 9:30am to 10:30am EDT
Monthly Oncology Tumor Boards: Management of Recurrent/Metastatic Cervical Cancer and Neuroendocrine Carcinoma of the Cervix
    • 1.00 CCM clock hours
    • 1.00 ANCC contact hours
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ACPE contact hours
    • 1.00 AAPA Category 1 CME credit
    • 1.00 Participation
 $0.00 11/30/2023 - 2:30pm to 3:30pm EST
Monthly Oncology Tumor Boards: Management of Advanced Ovarian Cancer
    • 1.00 CCM clock hours
    • 1.00 ANCC contact hours
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ACPE contact hours
    • 1.00 AAPA Category 1 CME credit
    • 1.00 Participation
 $0.00 12/06/2023 - 2:30pm to 3:30pm EST
NCCN Pharmacy Updates: Advances in Targeted Therapy for Biliary Tract Cancers
    • 1.00 ANCC contact hours
      • 1.00 ANCC Pharmacology Contact Hours
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ACPE contact hours
    • 1.00 AAPA Category 1 CME credit
    • 1.00 Participation
 $0.00 12/14/2023 - 1:00pm to 2:00pm EST
NCCN Pharmacy Updates: Updates in the Treatment of Adult Acute Lymphoblastic Leukemia
    • 1.00 ANCC contact hours
      • 1.00 ANCC Pharmacology Contact Hours
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ACPE contact hours
    • 1.00 AAPA Category 1 CME credit
    • 1.00 Participation
 $0.00 12/20/2023 - 12:30pm to 1:30pm EST

Featured Online Courses

Title Credit Type Event datesort descending Cost
Acute Myeloid Leukemia Patient Management Simulator Enduring $0.00
Diagnosis and Management of Breast Cancer: What does the Evidence Show, What are We Doing, And What’s on the Horizon?
    • 0.75 ANCC contact hours
    • 0.75 AMA PRA Category 1 Credit™
    • 0.75 AAPA Category 1 CME credit
    • 0.75 Participation
 Enduring $0.00
Evidence-Based Guidance on New Paradigms in the Treatment of Acute Myeloid Leukemia
    • 1.00 ANCC contact hours
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ACPE contact hours
    • 1.00 AAPA Category 1 CME credit
    • 1.00 Participation
 Enduring $0.00
The Evolving Landscape in CLL/SLL: Best Practice Clinical Applications of Current Evidence and New Guideline Recommendations
    • 1.75 ANCC contact hours
    • 1.75 AMA PRA Category 1 Credit™
    • 1.75 ACPE contact hours
    • 1.75 AAPA Category 1 CME credit
    • 1.75 Participation
 Enduring $0.00
Unlocking the Potential of Neoadjuvant and Adjuvant Immunotherapy in Resectable NSCLC: The Role of Checkpoint Inhibitors
    • 1.75 ANCC contact hours
    • 1.75 AMA PRA Category 1 Credit™
    • 1.75 AAPA Category 1 CME credit
    • 1.75 Participation
 Enduring $0.00

Transcript

Please login or create an account to view your activities.

Pending Activities

Please login or create an account to view your activities.